| 12091652 |
Ammonia-oxidizing Nitrosomonas eutropha strain D23 |
David R. Whitlock, Larry Weiss, Ioannis Gryllos |
2024-09-17 |
|
| 11225640 |
Ammonia oxidizing bacteria for treatment of psoriasis |
David R. Whitlock, Larry Weiss |
2022-01-18 |
|
| 10383900 |
Systems and methods for storage and delivery of ammonia oxidizing bacteria |
James Heywood, David R. Whitlock, Larry Weiss |
2019-08-20 |
|
| 10131871 |
Ammonia oxidizing bacteria for treatment of rosacea |
David R. Whitlock, Larry Weiss |
2018-11-20 |
|
| 10017731 |
Ammonia oxidizing bacteria for treatment of eczema |
David R. Whitlock, Larry Weiss |
2018-07-10 |
|
| 9738870 |
Ammonia oxidizing bacteria for treatment of acne |
David R. Whitlock, Larry Weiss |
2017-08-22 |
|
| 7566704 |
Very high molecular weight β-glucans |
Myra L. Patchen, D. Davidson Easson, Jr., Gary R. Ostroff |
2009-07-28 |
|
| 7022685 |
Very high molecular weight β-glucans |
Myra L. Patchen, D. Davidson Easson, Jr., Gary R. Ostroff |
2006-04-04 |
|
| 6369216 |
Very high molecular weight &bgr;-glucans |
Myra L. Patchen, D. Davidson Easson, Jr., Gary R. Ostroff |
2002-04-09 |
|
| 6143731 |
Glucan dietary additives |
D. Davidson Easson, Jr., Bruce R. Bistrian |
2000-11-07 |
|
| 6020324 |
Glucan dietary additives |
D. Davidson Easson, Jr., Bruce R. Bistrian |
2000-02-01 |
|
| 5849720 |
Enhancement of non-specific immune defenses by administration of underivatized, aqueous soluble glucans |
D. Davidson Easson, Jr., Gary R. Ostroff |
1998-12-15 |
$343,000 |
| 5817643 |
Underivatized, aqueous soluable .beta.(1-3) glucan, composition and method of making same |
D. Davidson Easson, Jr., Gary R. Ostroff |
1998-10-06 |
$538,000 |
| 5811542 |
Method for producing soluble glucans |
D. Davidson Easson, Jr., Gary R. Ostroff |
1998-09-22 |
$559,000 |
| 5783569 |
Uses for underivatized, aqueous soluble .beta.(1-3) glucan and compositions comprising same |
D. Davidson Easson, Jr., Gary R. Ostroff |
1998-07-21 |
$934,000 |
| 5741495 |
Glucan drug delivery system and adjuvant |
Gary R. Ostroff, D. Davidson Easson, Jr. |
1998-04-21 |
$720,000 |
| 5633369 |
Method for producing soluble glucans |
D. Davidson Easson, Jr., Gary R. Ostroff |
1997-05-27 |
$2,456,000 |
| 5622939 |
Glucan preparation |
D. Davidson Easson, Jr., Gary R. Ostroff |
1997-04-22 |
$1,141,000 |
| 5607677 |
Glucan drug delivery system and adjuvant |
Gary R. Ostroff, D. Davidson Easson, Jr. |
1997-03-04 |
$3,090,000 |
| 5532223 |
Use of aqueous soluble glucan preparations to stimulate platelet production |
D. Davidson Easson, Jr., Gary R. Ostroff |
1996-07-02 |
$3,216,000 |
| 5506124 |
Process for preparing glucanase resistant yeast mutants |
ChoKyun Rha, Anthony J. Sinskey |
1996-04-09 |
|
| 5504079 |
Method for immune system activation by administration of a .beta.(1-3) glucan which is produced by Saccharomyces cerevisiae strain R4 |
D. Davidson Easson, Jr., Gary R. Ostroff |
1996-04-02 |
$4,197,000 |
| 5488040 |
Use of neutral soluble glucan preparations to stimulate platelet production |
D. Davidson Easson, Jr., Gary R. Ostroff |
1996-01-30 |
$4,168,000 |
| 5322841 |
Method for producing neutral glucans for pharmaceutical applications |
D. Davidson Easson, Jr., Gary R. Ostroff |
1994-06-21 |
$1,932,000 |
| 5250436 |
Glucan compositions and process for preparation thereof |
ChoKyun Rha, Anthony J. Sinskey |
1993-10-05 |
|
